Theory Paper IIIDrNB Cardiology – Theory Notes
CAROTID ARTERY REVASCULARIZATION IN CORONARY ARTERY DISEASE
ICORE CLINICAL PARADIGM AND PATHOPHYSIOLOGY OF POST-CABG STROKE
- Reversal of Routine Prophylactic Carotid Surgery: Concomitant severe (>70 percent) internal carotid artery (ICA) stenosis is present in 6 to 8 percent of patients undergoing Coronary Artery Bypass Grafting (CABG). Historically, routine prophylactic Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) was performed before or during CABG; contemporary ESC (2018 Myocardial Revascularization / 2024 PAAD) and ACC/AHA Guidelines establish that routine prophylactic carotid revascularization in neurologically asymptomatic patients with unilateral carotid stenosis does NOT reduce perioperative stroke and is NOT recommended (Class III).
- Why Routine Prophylactic Carotid Intervention Fails to Prevent CABG Stroke:
- Predominance of Aortic Atheroembolism and Atrial Fibrillation (>85 to 90 Percent): The vast majority of strokes complicating CABG occur either outside the territory of the stenosed carotid artery or more than 24 hours post-operatively, driven by (1) atheroembolism from surgical manipulation, cannulation, and cross-clamping of a calcified/atherosclerotic ascending aorta, and (2) post-operative Atrial Fibrillation.
- Rarity of Ipsilateral Hemodynamic Watershed Hypoperfusion (<10 Percent): Less than 10 percent of post-CABG strokes result from low-flow watershed hypoperfusion distal to an asymptomatic unilateral carotid stenosis during cardiopulmonary bypass.
IILANDMARK CLINICAL TRIAL EVIDENCE
- CABACS Trial (Weimar et al., Stroke 2017 & 5-Year Follow-Up — Knipp et al., Stroke 2022):
- Design: Multicenter randomized controlled trial comparing synchronous CEA + CABG versus isolated CABG alone in patients with high-grade (>=80% ECST / >=70% NASCET) asymptomatic carotid artery stenosis.
- Results: The 30-day rate of composite non-fatal stroke or death was numerically higher with combined CEA + CABG than with isolated CABG alone (18.5 percent vs. 9.7 percent), and at 5-year follow-up, there was no significant difference in stroke or death—confirming that prophylactic synchronous CEA in asymptomatic carotid stenosis adds procedural hazard without neuroprotection.
- CREST Trial (Brott et al., NEJM 2010 — CEA vs. CAS Periprocedural Trade-Off):
- Key Finding Crucial for CAD Patients: While overall 4-year composite endpoints were similar between CEA and CAS, during the 30-day periprocedural period, CEA carried a significantly higher risk of Myocardial Infarction (2.3 percent vs. 1.1 percent; p = 0.03), whereas CAS carried a significantly higher risk of periprocedural Stroke (4.1 percent vs. 2.3 percent; p = 0.01).
- ACST-2 Trial (Lancet 2021): Confirmed in 3,625 asymptomatic patients without imminent cardiac surgery that CEA and CAS have comparable 1% disabling stroke/death risk and identical 5-year non-procedural stroke rates.
IIIGUIDELINE INDICATIONS FOR CAROTID REVASCULARIZATION IN PATIENTS UNDERGOING CABG (ESC 2018 / 2024 PAAD GUIDELINES)
- Mandatory Multidisciplinary Heart-Brain Team Consultation (Class I): Every patient scheduled for CABG with severe carotid disease must be evaluated by a multidisciplinary team including a neurologist, cardiologist, cardiac surgeon, and vascular specialist.
| Neurological Status (TIA or Stroke Within Past 6 Months) | Carotid Anatomy (NASCET Criteria) | ESC Guideline Class & Level of Evidence | Clinical Recommendation & High-Risk Modifiers |
|---|---|---|---|
| Symptomatic (TIA or retinal/hemispheric stroke within 6 months) | 70% to 99% Carotid Stenosis | Class IIa (Level B) — Should Be Considered (ESC 2018 covers 50–99%) | Carotid revascularization (CEA preferred over CAS or staged/synchronous per urgency) is indicated to prevent recurrent ipsilateral stroke |
| Symptomatic (TIA or stroke within 6 months) | 50% to 69% Carotid Stenosis | Class IIa (Level B) — Should Be Considered | Consider carotid revascularization depending on patient-specific surgical/clinical risk |
| Asymptomatic (No neurologic symptoms in past 6 months) | Unilateral 70% to 99% Carotid Stenosis | Class III (Level B) — Routine Prophylactic Revascularization NOT Recommended | Proceed directly to CABG alone with optimal medical therapy and mean arterial pressure >70 mmHg on bypass (CABACS Trial) |
| Asymptomatic (Bilateral Severe or Contralateral Occlusion) | Bilateral 70% to 99% Stenosis, OR 70% to 99% Stenosis + Contralateral Total Occlusion | Class IIb (Level C) — May Be Considered | May be considered selectively only if >=1 high-risk stroke feature is present (silent ipsilateral infarct on brain CT/MRI, intraplaque hemorrhage/ulceration, impaired cerebral vascular reserve, or progression) |
IVSTRATEGIC TIMING AND MODALITY SELECTION WHEN BOTH REQUIRE REVASCULARIZATION
- Clinical Principle: When carotid revascularization is indicated (e.g., recent symptomatic TIA/stroke with 70–99% ICA stenosis), the choice between staged vs. synchronous and CEA vs. CAS is dictated by which vascular bed is more clinically unstable:
- Staged CEA First, Followed by CABG: Preferred when the patient has acute/recent neurological symptoms (crescendo TIA or minor stroke) with stable multivessel CAD; carries a risk of perioperative myocardial infarction during the CEA if severe Left Main or unstable angina is present.
- Synchronous (Simultaneous) CEA + CABG Under Single Anesthesia: Performed by completing the carotid endarterectomy prior to sternotomy/cardiopulmonary bypass when both territories are unstable (e.g., recent TIA/stroke plus ACS, critical Left Main stenosis, or refractory angina).
- Staged or Hybrid Carotid Artery Stenting (CAS) + CABG (The DAPT Bleeding Trap):
- The Pharmacological Dilemma: Carotid Artery Stenting mandates 4 weeks of Dual Antiplatelet Therapy (DAPT: Aspirin + Clopidogrel) to prevent acute carotid stent thrombosis. Deferring CABG for 4 weeks exposes an unstable CAD patient to fatal MI, whereas performing on-pump CABG under full DAPT markedly increases major perioperative bleeding and re-exploration.
- When CAS is Considered: Reserved for patients with hostile neck anatomy (prior neck irradiation, radical neck dissection, high cervical bifurcation above C2, or contralateral vocal cord palsy) or when single-stage hybrid CAS immediately followed by CABG is performed in expert centers using carefully bridged antiplatelet/intravenous cangrelor or GP IIb/IIIa protocols.
VPERIOPERATIVE STROKE PREVENTION AND THE INDIAN CLINICAL CONTEXT
- Selective Carotid Duplex Screening Before CABG (ESC 2018): Routine carotid ultrasound in all CABG patients is not indicated; Duplex Ultrasound is Class I in patients with TIA or stroke within 6 months, and may be considered (Class IIb) in those with a carotid bruit, age >=70 years, multivessel CAD or concomitant Peripheral Arterial Disease (PAD).
- Addressing the True Culprit — Epiaortic Ultrasound and “Anaortic / No-Touch” Off-Pump CABG: Because ascending aortic atheroma is the primary source of post-CABG stroke in Indian patients with diffuse calcific atherosclerosis, performing intraoperative Epiaortic Ultrasound before cannulation/clamping and utilizing “Anaortic” (No-Touch Aorta) Off-Pump CABG with bilateral internal mammary artery (BIMA) composite T/Y grafts is far more effective at preventing perioperative stroke than prophylactic CEA.
- Excluding Takayasu Arteritis in Young Indian Patients: In young Indian patients (especially women under 40 years) presenting with concomitant carotid stenosis/bruits and ostial coronary angina, Takayasu Arteritis (Type I / Type V aortoarteritis) must be excluded via CTA/PET-CT and inflammatory markers (ESR/hs-CRP). Performing surgical or endovascular revascularization during active vascular inflammation carries a very high rate of graft occlusion and anastomotic pseudoaneurysm; inflammation must first be suppressed with corticosteroids and steroid-sparing immunosuppressants unless an acute life- or organ-threatening emergency mandates intervention.
Key references
- Neumann FJ, Sousa-Uva M, Ahlsson A, et al.: 2018 ESC/EACTS Guidelines on myocardial revascularization, European Heart Journal, 2019.
- Mazzolai L, Teixido-Tura G, Lanzi S, et al.: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases, European Heart Journal, 2024.
- Weimar C, Bilbilis K, Rekowski J, et al. & Knipp SC, et al. (CABACS Trial Investigators): Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting: A Randomized Clinical Trial (and 5-Year Follow-Up), Stroke, 2017 / 2022.
- Brott TG, Hobson RW II, Howard G, et al. (CREST Investigators): Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis, New England Journal of Medicine, 2010.
meritmedscript.comDr. Sidhartha Mullapudi
